Effect of alendronate on bone remodeling around implant in the rat.
- Author:
Ran PARK
1
;
Jee Hwan KIM
;
Hyunmin CHOI
;
Young Bum PARK
;
Han Sung JUNG
;
Hong Seok MOON
Author Information
- Publication Type:Original Article
- Keywords: Alendronate; Bone remodeling; Bisphosphonate-related osteonecrosis of the jaw; Empty lacuna; Implant; Jaw
- MeSH: Alendronate*; Angiopoietin-1; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Remodeling*; Cell Count; Humans; Jaw; Male; Maxilla; Microarray Analysis; Molar; Osteocalcin; Osteoclasts; Rats*; Rats, Sprague-Dawley; Titanium
- From:The Journal of Advanced Prosthodontics 2013;5(4):374-381
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The purpose of this study was to evaluate the effect of alendronates on bone remodeling around titanium implant in the maxilla of rats. MATERIALS AND METHODS: The maxillary first molars were extracted and customized-titanium implants were placed immediately in thirty male Sprague-Dawley rats. The rats were divided into experimental (bisphosphonate) group and control group. At 4 weeks after implantation, the rats in the bisphosphonate group were subcutaneously injected with alendronate three times a week for 6 weeks where as the rats in control group were injected with saline. The rats were sacrificed at 1, 2, 3, 4, or 6 weeks after starting of injection and maxillary bones were collected subsequently. Alveolar bone remodeling around the implants were evaluated by radiographic and histologic analysis. Microarray analysis and immunohistomorphologic analysis were also performed on one rat, sacrificed at 6 weeks after starting of injection, from each group. Statistical analysis was performed using repeated measures analysis of variance and independent t test at a significance level of 5%. RESULTS: There was no statistically significant difference in the bone area (%) around implant between the bisphosphonate group and the control group. However, the amount of empty lacuna was significantly increased in the bisphosphonate group, especially in the rats sacrificed at 4 weeks after starting of injection compared to that of the corresponding control group. The bisphosphonate group showed the same level of TRAP positive cell count, osteocalcin and angiopoietin 1 as the control group. CONCLUSION: Alendronate may not decrease the amount of osteoclast. However, the significantly increased amount of empty lacuna in the bisphosphonate group may explain the suppression of bone remodeling in the bisphosphonate group.
